Related Experiment Video
Updated: May 2, 2026
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.4K
Lower macrophage migration inhibitory factor concentrations in maternal serum before pre-eclampsia onset
Simona Cardaropoli1, Francesca Ietta, Roberta Romagnoli
11 S.Anna Hospital , Turin, Italy .
Summary
Low maternal serum levels of macrophage migration inhibitory factor (MIF) in early pregnancy may indicate an increased risk for developing pre-eclampsia (PE). This finding could lead to earlier detection of PE.
Area of Science:
- Reproductive immunology
- Maternal-fetal medicine
Background:
- Macrophage migration inhibitory factor (MIF) is implicated in pregnancy-related inflammation.
- Altered MIF levels are linked to pregnancy complications like pre-eclampsia (PE).
Purpose of the Study:
- To determine if maternal MIF serum levels are altered in early pregnancy before PE onset.
- Investigate early pregnancy MIF as a potential biomarker for PE.
Main Methods:
- Prospective study of 2,821 pregnant women before 20 weeks gestation.
- Maternal serum MIF levels measured by ELISA in 48 PE cases and 79 controls.
- Comparison of MIF concentrations between women who developed PE and normotensive controls.
Main Results:
- Significantly lower MIF serum levels were observed in women who later developed PE (4,967 ± 3,119 pg/mL) compared to controls (7,640 ± 5,519 pg/mL).
- The difference in MIF levels was statistically significant (P<0.001).
Conclusions:
- Low maternal MIF serum levels in early pregnancy may be associated with abnormal placental development.
- MIF may serve as an early predictive marker for pre-eclampsia.
